{"id":501653,"date":"2021-06-08T07:10:01","date_gmt":"2021-06-08T11:10:01","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-joins-cell-and-gene-therapy-catapult-process-analytical-technology-consortium\/"},"modified":"2021-06-08T07:10:01","modified_gmt":"2021-06-08T11:10:01","slug":"bio-techne-joins-cell-and-gene-therapy-catapult-process-analytical-technology-consortium","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-joins-cell-and-gene-therapy-catapult-process-analytical-technology-consortium\/","title":{"rendered":"Bio-Techne Joins Cell and Gene Therapy Catapult Process Analytical Technology Consortium"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">MINNEAPOLIS<\/span>, <span class=\"xn-chron\">June 8, 2021<\/span> \/PRNewswire\/ &#8212;\u00a0Bio-Techne Corporation (NASDAQ: TECH) today announced it is joining the Cell and Gene Therapy Catapult process analytical technology (PAT) consortium, which includes over 20 pharmaceutical companies, technology providers, therapy developers, and charities. \u00a0The consortium will assess the application and combination of multiple technologies for process analytics within the cell and gene therapy industry. <\/p>\n<p>The Cell and Gene Therapy Catapult PAT consortium is the first initiative of this scale, functional expertise, and mission within the cell and gene therapy industry, uniting companies and organizations from multiple industries to develop cell and gene therapy specific process analytical technologies.\u00a0 The collaborative approach and sharing of research findings will accelerate the consortium&#8217;s collective expertise, allowing members to integrate and combine cell and gene therapy PAT into their respective offerings. Developing industry specific process analytical technologies enables monitoring and control during the manufacturing process, improving batch yield and lowering manufacturing costs, contributing to accelerated progress commercializing cell and gene therapies. \u00a0<\/p>\n<p>&#8220;We are honored to join the Cell and Gene Therapy Catapult PAT consortium and anticipate the sharing of knowledge and data will help move the industry forward,&#8221; said <span class=\"xn-person\">Chuck Kummeth<\/span>, Bio-Techne&#8217;s President and Chief Executive Officer.\u00a0 &#8220;Bio-Techne remains very excited about the potential of these innovative therapies to improve patient outcomes and potentially eradicate certain diseases. Our leading portfolio of reagents and technologies for cell and gene therapy workflow play a critical role in lowering costs and ultimately increasing access to these emerging therapies.&#8221;\u00a0 <\/p>\n<p>\n        <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3186855-1&amp;h=2334123348&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2622877-1%26h%3D186692316%26u%3Dhttps%253A%252F%252Finvestors.bio-techne.com%252Fcompany-information%26a%3DAbout%2BBio-Techne%2BCorporation&amp;a=About+Bio-Techne+Corporation\" rel=\"nofollow noopener\">About Bio-Techne Corporation<\/a>\u00a0(NASDAQ: TECH)<\/p>\n<div>\n<table id=\"convertedTable68c3\" cellspacing=\"0\" cellpadding=\"0\" border=\"0\" class=\"prnbcc\">\n<tr>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">Contact: <\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">David Clair, Senior Director, Investor Relations and Corporate Development<\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\">\n              \n            <\/td>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\"><br \/>\n                  <a target=\"_blank\" href=\"mailto:david.clair@bio-techne.com\" class=\"prnews_a\" rel=\"nofollow noopener\">david.clair@bio-techne.com<\/a><br \/>\n                <\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\">\n              \n            <\/td>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">612-656-4416\u00a0<\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n<p>\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1269\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/363268\/Bio_Techne__Logo.html\" target=\"_blank\" rel=\"nofollow noopener\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/363268\/Bio_Techne__Logo.jpg\" title=\"Bio-Techne\" alt=\"Bio-Techne\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder0\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=CG01416&amp;sd=2021-06-08\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/bio-techne-joins-cell-and-gene-therapy-catapult-process-analytical-technology-consortium-301307476.html\">http:\/\/www.prnewswire.com\/news-releases\/bio-techne-joins-cell-and-gene-therapy-catapult-process-analytical-technology-consortium-301307476.html<\/a><\/p>\n<p>SOURCE  Bio-Techne Corporation<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=CG01416&amp;Transmission_Id=202106080700PR_NEWS_USPR_____CG01416&amp;DateId=20210608\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire MINNEAPOLIS, June 8, 2021 \/PRNewswire\/ &#8212;\u00a0Bio-Techne Corporation (NASDAQ: TECH) today announced it is joining the Cell and Gene Therapy Catapult process analytical technology (PAT) consortium, which includes over 20 pharmaceutical companies, technology providers, therapy developers, and charities. \u00a0The consortium will assess the application and combination of multiple technologies for process analytics within the cell and gene therapy industry. The Cell and Gene Therapy Catapult PAT consortium is the first initiative of this scale, functional expertise, and mission within the cell and gene therapy industry, uniting companies and organizations from multiple industries to develop cell and gene therapy specific process analytical technologies.\u00a0 The collaborative approach and sharing of research findings will accelerate the consortium&#8217;s collective expertise, allowing members to &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-joins-cell-and-gene-therapy-catapult-process-analytical-technology-consortium\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Bio-Techne Joins Cell and Gene Therapy Catapult Process Analytical Technology Consortium&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-501653","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Bio-Techne Joins Cell and Gene Therapy Catapult Process Analytical Technology Consortium - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-joins-cell-and-gene-therapy-catapult-process-analytical-technology-consortium\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bio-Techne Joins Cell and Gene Therapy Catapult Process Analytical Technology Consortium - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire MINNEAPOLIS, June 8, 2021 \/PRNewswire\/ &#8212;\u00a0Bio-Techne Corporation (NASDAQ: TECH) today announced it is joining the Cell and Gene Therapy Catapult process analytical technology (PAT) consortium, which includes over 20 pharmaceutical companies, technology providers, therapy developers, and charities. \u00a0The consortium will assess the application and combination of multiple technologies for process analytics within the cell and gene therapy industry. The Cell and Gene Therapy Catapult PAT consortium is the first initiative of this scale, functional expertise, and mission within the cell and gene therapy industry, uniting companies and organizations from multiple industries to develop cell and gene therapy specific process analytical technologies.\u00a0 The collaborative approach and sharing of research findings will accelerate the consortium&#8217;s collective expertise, allowing members to &hellip; Continue reading &quot;Bio-Techne Joins Cell and Gene Therapy Catapult Process Analytical Technology Consortium&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-joins-cell-and-gene-therapy-catapult-process-analytical-technology-consortium\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-08T11:10:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/363268\/Bio_Techne__Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-techne-joins-cell-and-gene-therapy-catapult-process-analytical-technology-consortium\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-techne-joins-cell-and-gene-therapy-catapult-process-analytical-technology-consortium\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Bio-Techne Joins Cell and Gene Therapy Catapult Process Analytical Technology Consortium\",\"datePublished\":\"2021-06-08T11:10:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-techne-joins-cell-and-gene-therapy-catapult-process-analytical-technology-consortium\\\/\"},\"wordCount\":292,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-techne-joins-cell-and-gene-therapy-catapult-process-analytical-technology-consortium\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/363268\\\/Bio_Techne__Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-techne-joins-cell-and-gene-therapy-catapult-process-analytical-technology-consortium\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-techne-joins-cell-and-gene-therapy-catapult-process-analytical-technology-consortium\\\/\",\"name\":\"Bio-Techne Joins Cell and Gene Therapy Catapult Process Analytical Technology Consortium - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-techne-joins-cell-and-gene-therapy-catapult-process-analytical-technology-consortium\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-techne-joins-cell-and-gene-therapy-catapult-process-analytical-technology-consortium\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/363268\\\/Bio_Techne__Logo.jpg\",\"datePublished\":\"2021-06-08T11:10:01+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-techne-joins-cell-and-gene-therapy-catapult-process-analytical-technology-consortium\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-techne-joins-cell-and-gene-therapy-catapult-process-analytical-technology-consortium\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-techne-joins-cell-and-gene-therapy-catapult-process-analytical-technology-consortium\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/363268\\\/Bio_Techne__Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/363268\\\/Bio_Techne__Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-techne-joins-cell-and-gene-therapy-catapult-process-analytical-technology-consortium\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bio-Techne Joins Cell and Gene Therapy Catapult Process Analytical Technology Consortium\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bio-Techne Joins Cell and Gene Therapy Catapult Process Analytical Technology Consortium - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-joins-cell-and-gene-therapy-catapult-process-analytical-technology-consortium\/","og_locale":"en_US","og_type":"article","og_title":"Bio-Techne Joins Cell and Gene Therapy Catapult Process Analytical Technology Consortium - Market Newsdesk","og_description":"PR Newswire MINNEAPOLIS, June 8, 2021 \/PRNewswire\/ &#8212;\u00a0Bio-Techne Corporation (NASDAQ: TECH) today announced it is joining the Cell and Gene Therapy Catapult process analytical technology (PAT) consortium, which includes over 20 pharmaceutical companies, technology providers, therapy developers, and charities. \u00a0The consortium will assess the application and combination of multiple technologies for process analytics within the cell and gene therapy industry. The Cell and Gene Therapy Catapult PAT consortium is the first initiative of this scale, functional expertise, and mission within the cell and gene therapy industry, uniting companies and organizations from multiple industries to develop cell and gene therapy specific process analytical technologies.\u00a0 The collaborative approach and sharing of research findings will accelerate the consortium&#8217;s collective expertise, allowing members to &hellip; Continue reading \"Bio-Techne Joins Cell and Gene Therapy Catapult Process Analytical Technology Consortium\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-joins-cell-and-gene-therapy-catapult-process-analytical-technology-consortium\/","og_site_name":"Market Newsdesk","article_published_time":"2021-06-08T11:10:01+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/363268\/Bio_Techne__Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-joins-cell-and-gene-therapy-catapult-process-analytical-technology-consortium\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-joins-cell-and-gene-therapy-catapult-process-analytical-technology-consortium\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Bio-Techne Joins Cell and Gene Therapy Catapult Process Analytical Technology Consortium","datePublished":"2021-06-08T11:10:01+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-joins-cell-and-gene-therapy-catapult-process-analytical-technology-consortium\/"},"wordCount":292,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-joins-cell-and-gene-therapy-catapult-process-analytical-technology-consortium\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/363268\/Bio_Techne__Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-joins-cell-and-gene-therapy-catapult-process-analytical-technology-consortium\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-joins-cell-and-gene-therapy-catapult-process-analytical-technology-consortium\/","name":"Bio-Techne Joins Cell and Gene Therapy Catapult Process Analytical Technology Consortium - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-joins-cell-and-gene-therapy-catapult-process-analytical-technology-consortium\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-joins-cell-and-gene-therapy-catapult-process-analytical-technology-consortium\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/363268\/Bio_Techne__Logo.jpg","datePublished":"2021-06-08T11:10:01+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-joins-cell-and-gene-therapy-catapult-process-analytical-technology-consortium\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-joins-cell-and-gene-therapy-catapult-process-analytical-technology-consortium\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-joins-cell-and-gene-therapy-catapult-process-analytical-technology-consortium\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/363268\/Bio_Techne__Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/363268\/Bio_Techne__Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-joins-cell-and-gene-therapy-catapult-process-analytical-technology-consortium\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Bio-Techne Joins Cell and Gene Therapy Catapult Process Analytical Technology Consortium"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/501653","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=501653"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/501653\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=501653"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=501653"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=501653"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}